의료 시뮬레이션 시장 규모, 점유율, 동향 분석 리포트 : 제품·서비스별, 기술별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Medical Simulation Market Growth & Trends:

The global medical simulation market size is expected to reach a value of USD 4.19 billion by 2030. The market is expected to expand at a CAGR of 16.80% from 2025 to 2030. With recent technological advancements, the use of new medical devices and advanced procedures, such as enhanced mechanical ventilation devices, cardiac assist devices, and intra-cardiac echocardiography technology, is increasing; which drives the need for advanced training solutions, such as simulation, for customer training and internal product development. Certification and regulatory agencies are strictly recommending that physicians and clinicians be trained before the adoption of new, disruptive technologies. Although hands-on learning with real patients cannot be replaced, simulation training offers safe learning conditions. Students and medical residents making mistakes in this phase is an important part of the learning process, as in simulation training patients are not put at risk.

Education Management Solutions, LLC- a company dealing in medical simulation learning management technology-released workflows that were COVID-19 contingency ready for healthcare education. CAE Healthcare responded to the pandemic by helping with a complimentary webinar, SCE, and outreach toolkit to assist educators. Such factors boosted the demand for medical simulation services during the pandemic.

The market is very competitive. The most notable market participants are CAE, Laerdal Medical, 3D Systems, Simulab Corporation, Limbs & Things Ltd, Mentice AB, Simulaids, Gaumard Scientific Company, Surgical Science Sweden AB, Kyoto Kagaku Co., Ltd and account for a considerable share owing to their product offerings to the market. Market leaders are involved in the establishment of extensive distribution systems as well as in mergers and acquisitions to capture a larger share of the market. For instance, in January 2021, Gaumard Scientific Company revealed its ultrasound system and pediatric emergency scenario modules for Pediatric HAL.

Medical Simulation Market Report Highlights:

• Healthcare anatomical model dominated the products and services segment of the overall market in 2024, as these simulators are proving to be beneficial in the manufacturing and research industry for conducting trials.
• The hospitals end-user segment is expected to expand at the fastest CAGR of 16.6% over the forecast period. Factors responsible for the growth are the gradual shift of focus on advanced learning and increasing focus on minimizing errors.
• Procedural rehearsal technology is expected to be the largest technology segment. The rising number of medical errors leading to increasing demand for patient safety is expected to boost the demand for procedure rehearsal technology.
• The Asia Pacific region is anticipated to register rapid growth in the forthcoming years owing to the growing healthcare IT spending and rapidly evolving healthcare infrastructure.
• In February 2022, Surgical Science joined Mimic Technologies, thus expanding its foothold in the robotic surgery segment.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Segment Definition
    • 1.1.1.1 Product & Services Segment
    • 1.1.1.2 Technology Segment
    • 1.1.1.3 End Use Segment
• 1.2 Regional Scope
  • 1.2.1 Estimates and Forecast Timeline
• 1.3 Objectives
  • 1.3.1 Objective - 1
  • 1.3.2 Objective - 2
  • 1.3.3 Objective - 3
• 1.4 Research Methodology
• 1.5 Information Procurement
  • 1.5.1 Purchased Database
  • 1.5.2 GVR's Internal Database
  • 1.5.3 Secondary Sources
  • 1.5.4 Primary Research
  • 1.5.5 Details of Primary Research
• 1.6 Information or Data Analysis
  • 1.6.1 Data Analysis Models
• 1.7 Market Formulation & Validation
• 1.8 Model Details
  • 1.8.1 Consensus-Based Estimates & Forecasting
    • 1.8.1.1 Commodity Flow Analysis (Model 1)
      • 1.8.1.1.1 Segment-Level Company Revenue Estimates: A Key Example
    • 1.8.1.2 Parent market Analysis
    • 1.8.1.3 Secondary reliable published data
    • 1.8.1.4 Top-Down market estimation
    • 1.8.1.5 Country-based segment share calculation
    • 1.8.1.6 Medical Simulation Market: CAGR Calculation
• 1.9 List of Secondary Sources
• 1.10 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Outlook
• 2.3 Competitive Scenario

Chapter 3 Market Variables, Trends & Scope

• 3.1 Market Dynamics
  • 3.1.1 Market Driver Analysis
    • 3.1.1.1 Growing emphasis on patient safety and outcomes
    • 3.1.1.2 Shortage of qualified healthcare professionals
    • 3.1.1.3 Rising use of simulation, with a growing demand for innovative and custom training approaches to prevent medical errors
    • 3.1.1.4 Limited access to patients for educational and clinical development purposes
  • 3.1.2 Market Restraint Analysis
    • 3.1.2.1 High cost of simulators and limited investment in simulation systems
    • 3.1.2.2 Inadequately designed medical simulation equipment
• 3.2 Business Environment Analysis Tools
  • 3.2.1 Porter's Five Forces Analysis
  • 3.2.2 PESTL Analysis
• 3.3 Technology Overview
  • 3.3.1 Virtual Reality (VR) and Augmented Reality (AR)
  • 3.3.2 Artificial Intelligence (AI)
  • 3.3.3 Gamification
  • 3.3.4 Use of Multidisciplinary Approach in the Development of Simulators
  • 3.3.5 3D Printing
  • 3.3.6 HCIT/EMR-EHR
• 3.4 Impact of COVID-19 Pandemic
• 3.5 Estimated Number of End Users Per Product Type, at Regional Level

Chapter 4 Medical Simulation Market: Product & Services Estimates & Trend Analysis

• 4.1 Medical Simulation Product & Services Market: Segment Dashboard
• 4.2 Product Movement & Market Share Analysis, 2024 & 2030
• 4.3 Global Medical Simulation Market, Market Estimates & Forecast, by Product & Services
  • 4.3.1 Healthcare Anatomical Models
    • 4.3.1.1 Healthcare anatomical models market, 2018 - 2030 (USD Million)
    • 4.3.1.2 Type 1
      • 4.3.1.2.1 Patient Simulators
        • 4.3.1.2.1.1 Patient simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.2.1.2 Adult
          • 4.3.1.2.1.2.1 Adult market, 2018 - 2030 (USD Million)
        • 4.3.1.2.1.3 Pediatrics and Baby Care
          • 4.3.1.2.1.3.1 Pediatrics and baby care market, 2018 - 2030 (USD Million)
      • 4.3.1.2.2 Task Trainers
    • 4.3.1.2.2.1Task trainers market, 2018 - 2030 (USD Million)
    • 4.3.1.3 By Fidelity Type
      • 4.3.1.3.1 Low-fidelity
        • 4.3.1.3.1.1 Low-fidelity market, 2018 - 2030 (USD Million)
      • 4.3.1.3.2 Medium-fidelity
        • 4.3.1.3.2.1 Medium-fidelity simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.3.3 High-fidelity
        • 4.3.1.3.3.1 High-fidelity simulators market, 2018 - 2030 (USD Million)
    • 4.3.1.4 Type 2
      • 4.3.1.4.1 Interventional/Surgical Simulators
        • 4.3.1.4.1.1 Interventional/surgical simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.2 Laproscopic Surgical Simulators
          • 4.3.1.4.1.2.1 Laproscopic surgical simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.3 Gynecology Simulators
          • 4.3.1.4.1.3.1 Gynecology simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.4 Cardiovascular Simulators
          • 4.3.1.4.1.4.1 Cardiovascular simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.5 Arthroscopic Surgical Simulators
          • 4.3.1.4.1.5.1 Arthroscopic surgical simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.6 Spine Surgical Simulators
          • 4.3.1.4.1.6.1 Spine surgical simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.7 Other Interventional/Surgical Simulators
          • 4.3.1.4.1.7.1 Other interventional/surgical simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.4.2 Endovascular Simulators
        • 4.3.1.4.2.1 Endovascular simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.4.3 Ultrasound Simulators
        • 4.3.1.6.3.1 Ultrasound simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.4.4 Dental Simulators
        • 4.3.1.4.4.1 Dental simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.4.5 Eye Simulators
        • 4.3.1.4.5.1 Eye simulators market, 2018 - 2030 (USD Million)
  • 4.3.2 Healthcare Simulation Software (Inclusive of Web-Based Simulators)
    • 4.3.2.1 Healthcare simulation software market, 2018 - 2030 (USD Million)
  • 4.3.3 Simulation Training Services
    • 4.3.3.1 Simulation training services market, 2018 - 2030 (USD Million)

Chapter 5 Medical Simulation Market: Technology Estimates & Trend Analysis

• 5.1 Medical Simulation Technology Market: Segment Dashboard
• 5.2 Technology Movement & Market Share Analysis, 2024 & 2030
• 5.3 Global Medical Simulation Market, Market Estimates & Forecast, by Technology
  • 5.3.1 Virtual Patient Simulation
    • 5.3.1.1 Virtual patient simulation market, 2018 - 2030 (USD Million)
  • 5.3.2 3D Printing
    • 5.3.2.1 3D printing market, 2018 - 2030 (USD Million)
  • 5.3.3 Procedure Rehearsal Technology
    • 5.3.3.1 Procedure rehearsal technology market, 2018 - 2030 (USD Million)

Chapter 6 Medical Simulation Market: End Use Estimates & Trend Analysis

• 6.1 Medical Simulation End Use Market: Segment Dashboard
• 6.2 Instrument Movement & Market Share Analysis, 2024 & 2030
• 6.3 Global Medical Simulation Market, Market Estimates & Forecast, by End Use
  • 6.3.1 Hospitals
    • 6.3.1.1 Hospitals market, 2018 - 2030 (USD Million)
  • 6.3.2 Research
    • 6.3.2.1 Research market, 2018 - 2030 (USD Million)
    • 6.3.2.2 Medical Device Companies
      • 6.3.2.2.1 Medical device companies market, 2018 - 2030 (USD Million)
    • 6.3.2.3 Others
      • 6.3.2.3.1 Others market, 2018 - 2030 (USD Million)
  • 6.3.3 Academic Institutes
    • 6.3.3.1 Academic institutes market, 2018 - 2030 (USD Million)
  • 6.3.4 Military Organizations
    • 6.3.4.1 Military organizations, 2018 - 2030 (USD Million)

Chapter 7 Regional Outlook

• 7.1 Regional Outlook
• 7.2 Medical Simulation Market by Region: Key Marketplace Takeaway
• 7.3 North America
  • 7.3.1 North America Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
  • 7.3.2 U.S.
    • 7.3.2.1 Key country dynamics
    • 7.3.2.2 U.S. medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.3.2.3 Competitive scenario
    • 7.3.2.4 Regulatory scenario
  • 7.3.3 Canada
    • 7.3.3.1 Key country dynamics
    • 7.3.3.2 Canada medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.3.3.3 Competitive scenario
    • 7.3.3.4 Regulatory scenario
  • 7.3.4 Mexico
    • 7.3.4.1 Key country dynamics
    • 7.3.4.2 Mexico medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.3.4.3 Competitive scenario
    • 7.3.4.4 Regulatory scenario
• 7.4 Europe
  • 7.4.1 Europe Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
  • 7.4.2 UK
    • 7.4.2.1 Key country dynamics
    • 7.4.2.2 UK medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2.3 Competitive scenario
    • 7.4.2.4 Regulatory scenario
  • 7.4.3 Germany
    • 7.4.3.1 Key country dynamics
    • 7.4.3.2 Germany medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3.3 Competitive scenario
    • 7.4.3.4 Regulatory scenario
  • 7.4.4 France
    • 7.4.4.1 Key country dynamics
    • 7.4.4.2 France medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4.3 Competitive scenario
    • 7.4.4.4 Regulatory scenario
  • 7.4.5 Italy
    • 7.4.5.1 Key country dynamics
    • 7.4.5.2 Italy medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5.3 Competitive scenario
    • 7.4.5.4 Regulatory scenario
  • 7.4.6 Spain
    • 7.4.6.1 Key country dynamics
    • 7.4.6.2 Spain medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6.3 Competitive scenario
    • 7.4.6.4 Regulatory and reimbursement scenario
  • 7.4.7 Denmark
    • 7.4.7.1 Key country dynamics
    • 7.4.7.2 Denmark medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.7.3 Competitive scenario
    • 7.4.7.4 Regulatory and reimbursement scenario
  • 7.4.8 Sweden
    • 7.4.8.1 Key country dynamics
    • 7.4.8.2 Sweden medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.8.3 Competitive scenario
    • 7.4.8.4 Regulatory scenario
  • 7.4.9 Norway
    • 7.4.9.1 Key country dynamics
    • 7.4.9.2 Norway medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.9.3 Competitive scenario
    • 7.4.9.4 Regulatory and reimbursement scenario
• 7.5 Asia Pacific
  • 7.5.1 Asia Pacific Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
  • 7.5.2 Japan
    • 7.5.2.1 Key country dynamics
    • 7.5.2.2 Japan medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.2.3 Competitive scenario
    • 7.5.2.4 Regulatory scenario
  • 7.5.3 China
    • 7.5.3.1 Key country dynamics
    • 7.5.3.2 China medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.3.3 Competitive scenario
    • 7.5.3.4 Regulatory scenario
  • 7.5.4 India
    • 7.5.4.1 Key country dynamics
    • 7.5.4.2 India medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.4.3 Competitive scenario
    • 7.5.4.4 Regulatory scenario
  • 7.5.5 Australia
    • 7.5.5.1 Key country dynamics
    • 7.5.5.2 Australia medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.5.3 Competitive scenario
    • 7.5.5.4 Regulatory scenario
  • 7.5.6 South Korea
    • 7.5.6.1 Key country dynamics
    • 7.5.6.2 South Korea medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.6.3 Competitive scenario
    • 7.5.6.4 Regulatory scenario
  • 7.5.7 Thailand
    • 7.5.7.1 Key country dynamics
    • 7.5.7.2 Thailand medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.7.3 Competitive scenario
    • 7.5.7.4 Regulatory scenario
• 7.6 Latin America
  • 7.6.1 Latin America Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
  • 7.6.2 Brazil
    • 7.6.2.1 Key country dynamics
    • 7.6.2.2 Brazil medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.6.2.3 Competitive scenario
    • 7.6.2.4 Regulatory scenario
  • 7.6.3 Argentina
    • 7.6.3.1 Key country dynamics
    • 7.6.3.2 Argentina medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.6.3.3 Competitive scenario
    • 7.6.3.4 Regulatory scenario
• 7.7 Middle East & Africa (MEA)
  • 7.7.1 MEA Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
  • 7.7.2 South Africa
    • 7.7.2.1 Key country dynamics
    • 7.7.2.2 South Africa medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.7.2.3 Competitive scenario
    • 7.7.2.4 Regulatory scenario
  • 7.7.3 Saudi Arabia
    • 7.7.3.1 Key country dynamics
    • 7.7.3.2 Saudi Arabia medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.7.3.3 Competitive scenario
    • 7.7.3.4 Regulatory scenario
  • 7.7.4 UAE
    • 7.7.4.1 Key country dynamics
    • 7.7.4.2 UAE medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.7.4.3 Competitive scenario
    • 7.7.4.4 Regulatory scenario
  • 7.7.5 Kuwait
    • 7.7.5.1 Key country dynamics
    • 7.7.5.2 Kuwait medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.7.5.3 Competitive scenario
    • 7.7.5.4 Regulatory scenario

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. CAE, Inc. (Madison Industries acquired CAE healthcare division in October 2023)
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Laerdal Medical
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. 3D Systems, Inc.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Simulab Corporation
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Limbs & Things Ltd
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Simulaids
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Kyoto Kagaku Co., Ltd
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Gaumard Scientific
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Mentice
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Surgical Science Sweden AB
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. Intelligent Ultrasound
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. Operative Experience, Inc.
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. Cardionics, Inc.
    • 8.4.13.1. Company overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Product benchmarking
    • 8.4.13.4. Strategic initiatives
  • 8.4.14. VirtaMed AG
    • 8.4.14.1. Company overview
    • 8.4.14.2. Financial performance
    • 8.4.14.3. Product benchmarking
    • 8.4.14.4. Strategic initiatives
  • 8.4.15. SYNBONE AG
    • 8.4.15.1. Company overview
    • 8.4.15.2. Financial performance
    • 8.4.15.3. Product benchmarking
    • 8.4.15.4. Strategic initiatives
  • 8.4.16. IngMar Medical
    • 8.4.16.1. Company overview
    • 8.4.16.2. Financial performance
    • 8.4.16.3. Product benchmarking
    • 8.4.16.4. Strategic initiatives
  • 8.4.17. TruCorp
    • 8.4.17.1. Company overview
    • 8.4.17.2. Financial performance
    • 8.4.17.3. Product benchmarking
    • 8.4.17.4. Strategic initiatives
  • 8.4.18. KaVo Dental
    • 8.4.18.1. Company overview
    • 8.4.18.2. Financial performance
    • 8.4.18.3. Product benchmarking
    • 8.4.18.4. Strategic initiatives
  • 8.4.19. Simendo
    • 8.4.19.1. Company overview
    • 8.4.19.2. Financial performance
    • 8.4.19.3. Product benchmarking
    • 8.4.19.4. Strategic initiatives
  • 8.4.20. Haag-Streit
    • 8.4.20.1. Company overview
    • 8.4.20.2. Financial performance
    • 8.4.20.3. Product benchmarking
    • 8.4.20.4. Strategic initiatives
  • 8.4.21. Symgery
    • 8.4.21.1. Company overview
    • 8.4.21.2. Financial performance
    • 8.4.21.3. Product benchmarking
    • 8.4.21.4. Strategic initiatives
  • 8.4.22. HRV Simulation
    • 8.4.22.1. Company overview
    • 8.4.22.2. Financial performance
    • 8.4.22.3. Product benchmarking
    • 8.4.22.4. Strategic initiatives
  • 8.4.23. Synaptive Medical
    • 8.4.23.1. Company overview
    • 8.4.23.2. Financial performance
    • 8.4.23.3. Product benchmarking
    • 8.4.23.4. Strategic initiatives
  • 8.4.24. Inovus Limited
    • 8.4.24.1. Company overview
    • 8.4.24.2. Financial performance
    • 8.4.24.3. Product benchmarking
    • 8.4.24.4. Strategic initiatives